Loading...
GT Biopharma, Inc.
GTBP.PA•EURONEXT
HealthcareBiotechnology
€280.50
€0.00(0.00%)
GT Biopharma, Inc. (GTBP.PA) Financial Performance & Statements
Review GT Biopharma, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-5.80%
↓ 5.80%
Net Income Growth
-73.25%
↓ 73.25%
Operating Cash Flow Growth
-45.77%
↓ 45.77%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-468.11%
↓ 468.11%
ROIC
860.12%
↑ 860.12%
GT Biopharma, Inc. (GTBP.PA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for GT Biopharma, Inc. stock.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $1.31M | $1.78M | $777000.00 | $1.36M |
| SG&A Expenses | $2.30M | $2.12M | $2.31M | $1.81M |
| Operating Expenses | $3.60M | $3.91M | $3.09M | $3.17M |
| Total Costs & Expenses | $3.60M | $3.91M | $3.09M | $3.17M |
| Interest Income | $96000.00 | $105000.00 | $142000.00 | $180000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $193000.00 | $196000.00 | $3.09M | $43812.00 |
| EBITDA | -$3.41M | -$3.71M | $825000.00 | -$2.96M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$3.60M | -$3.91M | -$3.09M | -$3.17M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $193000.00 | $196000.00 | $825000.00 | $206000.00 |
| Income Before Tax | -$3.41M | -$3.71M | -$2.27M | -$2.96M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | -$3.09M | -$180000.00 |
| Net Income | -$3.41M | -$3.71M | -$2.27M | -$2.96M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$1.53 | -$2.17 | -$1.64 | -$2.15 |
| Diluted EPS | -$1.53 | -$2.17 | -$1.64 | -$2.15 |
| Weighted Avg Shares Outstanding | $2.23M | $1.71M | $1.38M | $1.38M |
| Weighted Avg Shares Outstanding (Diluted) | $2.23M | $1.71M | $1.38M | $1.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan